Open Access

Global serum metabolomics profiling of colorectal cancer (Review)

  • Authors:
    • Nurul Azmir Amir Hashim
    • Sharaniza Ab‑Rahim
    • Leny Suzana Suddin
    • Mohd Shahril Ahmad Saman
    • Musalmah Mazlan
  • View Affiliations

  • Published online on: May 8, 2019     https://doi.org/10.3892/mco.2019.1853
  • Pages: 3-14
  • Copyright: © Amir Hashim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Accurate diagnosis of colorectal cancer (CRC) relies on the use of invasive tools such as colonoscopy and sigmoidoscopy. Non‑invasive tools are less sensitive in detecting the disease, particularly in the early stage. A number of researchers have used metabolomics analyses on serum/plasma samples of patients with CRC compared with normal healthy individuals in an effort to identify biomarkers for CRC. The aim of the present review is to compare reported serum metabolomics profiles of CRC and to identify common metabolites affected among these studies. A literature search was performed to include any experimental studies on global metabolomics profile of CRC using serum/plasma samples published up to March 2018. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool was used to assess the quality of the studies reviewed. In total, nine studies were included. The studies used various analytical platforms and were performed on different populations. A pathway enrichment analysis was performed using the data from all the studies under review. The most affected pathways identified were protein biosynthesis, urea cycle, ammonia recycling, alanine metabolism, glutathione metabolism and citric acid cycle. The metabolomics analysis revealed levels of metabolites of glycolysis, tricarboxylic acid cycle, anaerobic respiration, protein, lipid and glutathione metabolism were significantly different between cancer and control samples. Although the majority of differentiating metabolites identified were different in the different studies, there were several metabolites that were common. These metabolites include pyruvic acid, glucose, lactic acid, malic acid, fumaric acid, 3‑hydroxybutyric acid, tryptophan, phenylalanine, tyrosine, creatinine and ornithine. The consistent dysregulation of these metabolites among the different studies suggest the possibility of common diagnostic biomarkers for CRC.

References

1 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Zhu J, Djukovic D, Deng L, Gu H, Himmati F, Abu Zaid M, Chiorean EG and Raftery D: Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring. Anal Bioanal Chem. 407:7857–7863. 2015. View Article : Google Scholar : PubMed/NCBI

3 

American Cancer Society: Cancer facts and figures 2013. simplehttps://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2013/cancer-facts-and-figures-2013.pdfAccessed Month day, year.

4 

Wang D, Li W, Zou Q, Yin L, Du Y, Gu J and Suo J: Serum metabolomic profiling of human gastric cancer and its relationship with the prognosis. Oncotarget. 8:110000–110015. 2017.PubMed/NCBI

5 

Chinnaiyan P, Kensicki E, Bloom G, Prabhu A, Sarcar B, Kahali S, Eschrich S, Qu X, Forsyth P and Gillies R: The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res. 72:5878–5888. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Hadi NI, Jamal Q, Iqbal A, Shaikh F, Somroo S and Musharraf SG: Serum metabolomic profiles for breast cancer diagnosis, grading and staging by gas chromatography-mass spectrometry. Sci Rep. 7:17152017. View Article : Google Scholar : PubMed/NCBI

7 

Kumar N, Shahjaman M, Mollah MNH, Islam SMS and Hoque MA: Serum and plasma metabolomic biomarkers for lung cancer. Bioinformation. 13:202–208. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM and Kleijnen J: The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 3:252003. View Article : Google Scholar : PubMed/NCBI

9 

Ma Y, Liu W, Peng J, Huang L, Zhang P, Zhao X, Cheng Y and Qin H: A pilot study of gas chromatograph/mass spectrometry-based serum metabolic profiling of colorectal cancer after operation. Mol Biol Rep. 37:1403–1411. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Bertini I, Cacciatore S, Jensen BV, Schou JV, Johansen JS, Kruhøffer M, Luchinat C, Nielsen DL and Turano P: Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res. 72:356–364. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Zhu J, Djukovic D, Deng L, Gu H, Himmati F, Chiorean EG and Raftery D: Colorectal cancer detection using targeted serum metabolic profiling. J Proteome Res. 13:4120–4130. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Guertin KA, Loftfield E, Boca SM, Sampson JN, Moore SC, Xiao Q, Huang WY, Xiong X, Freedman ND, Cross AJ and Sinha R: Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. Am J Clin Nutr. 101:1000–1011. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Dowling P, Hughes DJ, Larkin AM, Meiller J, Henry M, Meleady P, Lynch V, Pardini B, Naccarati A, Levy M, et al: Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer. Clin Chim Acta. 441:133–141. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Crotti S, Agnoletto E, Cancemi G, Di Marco V, Traldi P, Pucciarelli S, Nitti D and Agostini M: Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker. Anal Bioanal Chem. 408:6321–6328. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Farshidfar F, Weljie AM, Kopciuk K, Buie WD, Maclean A, Dixon E, Sutherland FR, Molckovsky A, Vogel HJ and Bathe OF: Serum metabolomic profile as a means to distinguish stage of colorectal cancer. Genome Med. 4:422012. View Article : Google Scholar : PubMed/NCBI

16 

Farshidfar F, Weljie AM, Kopciuk KA, Hilsden R, McGregor SE, Buie WD, MacLean A, Vogel HJ and Bathe OF: A validated metabolomic signature for colorectal cancer: Exploration of the clinical value of metabolomics. Br J Cancer. 115:848–857. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Vahabi F, Sadeghi S, Arjmand M, Mirkhani F, Hosseini E, Mehrabanfar M, Hajhosseini R, Iravani A, Bayat P and Zamani Z: Staging of colorectal cancer using serum metabolomics with 1HNMR Spectroscopy. Iran J Basic Med Sci. 20:835–840. 2017.PubMed/NCBI

18 

Shu X, Xiang YB, Rothman N, Yu D, Li HL, Yang G, Cai H, Ma X, Lan Q, Gao YT, et al: Prospective study of blood metabolites associated with colorectal cancer risk. Int J Cancer. 143:527–534. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S and Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 8:4844–4850. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Nishiumi S, Kobayashi T, Ikeda A, Yoshie T, Kibi M, Izumi Y, Okuno T, Hayashi N, Kawano S, Takenawa T, et al: A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One. 7:e404592012. View Article : Google Scholar : PubMed/NCBI

21 

Tan B, Qiu Y, Zou X, Chen T, Xie G, Cheng Y, Dong T, Zhao L, Feng B, Hu X, et al: Metabonomics identifies serum metabolite markers of colorectal cancer. J Proteome Res. 12:3000–3009. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Cross A, Moore SC, Boca S, Huang WY, Xiong X, Stolzenberg-Solomon R, Sinha R and Sampson JN: A prospective study of serum metabolites and colorectal cancer risk. Cancer. 120:3049–3057. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Zamani Z, Arjmand M, Vahabi F, Eshaq Hosseini SM, Fazeli SM, Iravani A, Bayat P, Oghalayee A, Mehrabanfar M, Haj Hosseini R, et al: A metabolic study on colon cancer using (1)h nuclear magnetic resonance spectroscopy. Biochem Res Int. 2014:3487122014. View Article : Google Scholar : PubMed/NCBI

24 

Deng L, Gu H, Zhu J, Nagana Gowda GA, Djukovic D, Chiorean EG and Raftery D: Combining NMR and LC/MS using backward variable elimination: Metabolomics analysis of colorectal cancer, polyps, and healthy controls. Anal Chem. 88:7975–7983. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Uchiyama K, Yagi N, Mizushima K, Higashimura Y, Hirai Y, Okayama T, Yoshida N, Katada K, Kamada K, Handa O, et al: Serum metabolomics analysis for early detection of colorectal cancer. J Gastroenterol. 52:677–694. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Long Y, Sanchez-Espiridion B, Lin M, White L, Mishra L, Raju GS, Kopetz S, Eng C, Hildebrandt MAT, Chang DW, et al: Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. 123:4066–4074. 2017. View Article : Google Scholar : PubMed/NCBI

27 

Nishiumi S, Kobayashi T, Kawana S, Unno Y, Sakai T, Okamoto K, Yamada Y, Sudo K, Yamaji T, Saito Y, et al: Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry. Oncotarget. 8:17115–17126. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Kim SJ, Kim SH, Kim JH, Hwang S and Yoo HJ: Understanding metabolomics in biomedical research. Endocrinol Metab (Seoul). 31:7–16. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, Brown M, Knowles JD, Halsall A, Haselden JN, et al: Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 6:1060–1083. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Serkova NJ, Standiford TJ and Stringer KA: The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med. 184:647–655. 2011. View Article : Google Scholar : PubMed/NCBI

31 

Kastenmüller G, Raffler J, Gieger C and Suhre K: Genetics of human metabolism: An update. Hum Mol Genet. 24:R93–R101. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Ahn CS and Metallo CM: Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab. 3:12015. View Article : Google Scholar : PubMed/NCBI

33 

Hay N: Reprogramming glucose metabolism in cancer: Can it be exploited for cancer therapy? Nat Rev Cancer. 16:635–649. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Jain RK, Munn LL and Fukumura D: Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer. 2:266–276. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell. 148:399–408. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Kaelin WG Jr and Ratcliffe PJ: Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell. 30:393–402. 2008. View Article : Google Scholar : PubMed/NCBI

37 

Ananieva E: Targeting amino acid metabolism in cancer growth and anti-tumor immune response. World J Biol Chem. 6:281–289. 2015. View Article : Google Scholar : PubMed/NCBI

38 

Prendergast GC, Smith C, Thomas S, Mandik-Nayak L, Laury-Kleintop L, Metz R and Muller AJ: Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer. Cancer Immunol Immunother. 63:721–735. 2014. View Article : Google Scholar : PubMed/NCBI

39 

Peters JC: Tryptophan nutrition and metabolism: An overview. Adv Exp Med Biol. 294:345–358. 1991. View Article : Google Scholar : PubMed/NCBI

40 

Grohmann U and Bronte V: Control of immune response by amino acid metabolism. Immunol Rev. 236:243–264. 2010. View Article : Google Scholar : PubMed/NCBI

41 

Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ and Bradfield CA: An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 185:3190–3198. 2010. View Article : Google Scholar : PubMed/NCBI

42 

Hitosugi T, Fan J, Chung TW, Lythgoe K, Wang X, Xie J, Ge Q, Gu TL, Polakiewicz RD, Roesel JL, et al: Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell. 44:864–877. 2011. View Article : Google Scholar : PubMed/NCBI

43 

Pegg AE: Functions of polyamines in mammals. J Biol Chem. 291:14904–14912. 2016. View Article : Google Scholar : PubMed/NCBI

44 

Hoshino Y, Terashima S, Teranishi Y, Terashima M, Kogure M, Saitoh T, Osuka F, Kashimura S, Saze Z and Gotoh M: Ornithine decarboxylase activity as a prognostic marker for colorectal cancer. Fukushima J Med Sci. 53:1–9. 2007. View Article : Google Scholar : PubMed/NCBI

45 

Santos CR and Schulze A: Lipid metabolism in cancer. FEBS J. 279:2610–2623. 2012. View Article : Google Scholar : PubMed/NCBI

46 

Menendez JA and Lupu R: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 7:763–777. 2007. View Article : Google Scholar : PubMed/NCBI

47 

Benlloch M, Ortega A, Ferrer P, Segarra R, Obrador E, Asensi M, Carretero J and Estrela JM: Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity. J Biol Chem. 280:6950–6959. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

July 2019
Volume 11 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Amir Hashim, N.A., Ab‑Rahim, S., Suddin, L.S., Ahmad Saman, M.S., & Mazlan, M. (2019). Global serum metabolomics profiling of colorectal cancer (Review). Molecular and Clinical Oncology, 11, 3-14. https://doi.org/10.3892/mco.2019.1853
MLA
Amir Hashim, N. A., Ab‑Rahim, S., Suddin, L. S., Ahmad Saman, M. S., Mazlan, M."Global serum metabolomics profiling of colorectal cancer (Review)". Molecular and Clinical Oncology 11.1 (2019): 3-14.
Chicago
Amir Hashim, N. A., Ab‑Rahim, S., Suddin, L. S., Ahmad Saman, M. S., Mazlan, M."Global serum metabolomics profiling of colorectal cancer (Review)". Molecular and Clinical Oncology 11, no. 1 (2019): 3-14. https://doi.org/10.3892/mco.2019.1853